Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-15-048429
Filing Date
2015-10-05
Accepted
2015-10-05 11:15:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 205352
  Complete submission text file 0000000000-15-048429.txt   283594
Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filed for) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances